🔎 Trials Near Me

Home › Kanser sa Esophagus › Michigan › Grand Rapids

Pag-aaral pangklinika para sa Kanser sa Esophagus sa Grand Rapids, MI

14 pag-aaral para sa Kanser sa Esophagus ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Grand Rapids (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Nagre-recruitPhase 1
  • START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06465069

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Pan-tumor MRD Study

Nagre-recruitObservasyonal na pag-aaral
  • The Cancer & Hematology Centers (CHC), Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06605404

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Nagre-recruitPhase 1
  • BAMF Health Inc., Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Nagre-recruitPhase 1
  • BAMF Health Inc., Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2
  • START Midwest, Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Nagre-recruitObservasyonal na pag-aaral
  • Cancer & Hematology Centers of Western Michigan, Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

Nagre-recruitPhase 1/2
  • The Cancer and Hematology Centers ( Site 8912), Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06445972

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Nagre-recruitPhase 1/2
  • The Cancer and Hematology Centers ( Site 6912), Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06469944

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • START Midwest, Grand Rapids
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT06943521

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

Nagre-recruitPhase 1/2
  • BAMF Health, Inc., Grand Rapids
Edad 15 pataas · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT06298916

Pag-aaral para sa Kanser sa Esophagus sa ibang lungsod

Iba pang pag-aaral sa Grand Rapids

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.